Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.CardioVascular BioTherapeutics has opened two additional hospitals in the US for patient enrollment in its Acord Phase II clinical trial for the treatment of severe coronary heart disease.
Subscribe to our email newsletter
The sites are University of California Medical Center San Diego, California and Holy Cross Hospital, Fort Lauderdale, Florida.
Mercy Hospital Fairfield, Ohio and The Christ Hospital in Cincinnati, Ohio were first to open for enrollment in early September 2008, and are working in collaboration to screen and treat patients in the trial. They treated their first patient in support of the trial in mid November 2008.
CardioVascular BioTherapeutics (CVBT) now has five sites that are open for enrollment and intends to announce additional sites as they open for screening patents.